1. Academic Validation
  2. PF1163A, a novel antifungal agent, inhibit ergosterol biosynthesis at C-4 sterol methyl oxidase

PF1163A, a novel antifungal agent, inhibit ergosterol biosynthesis at C-4 sterol methyl oxidase

  • J Antibiot (Tokyo). 2002 Nov;55(11):969-74. doi: 10.7164/antibiotics.55.969.
Hiroshi Nose 1 Hideki Fushimi Asako Seki Toru Sasaki Hiroomi Watabe Shigeru Hoshiko
Affiliations

Affiliation

  • 1 Drug Discovery, Pharmaceutical Research Center, Meiji Seika Kaisha, Ltd., 760 Morooka-cho, Kohoku-ku, Yokohama 222-0002, Japan. hiroshi_nose@meiji.co.jp
Abstract

PF1163A and B are a pair of Antifungal agents isolated from a fermentation broth of Penicillium sp. PF1163A inhibited ergosterol synthesis in Saccharomyces cerevisiae, resulting in an accumulation of 4,4-dimethylzymosterol and a decrease of ergosterol. The ERG25 strain overexpressing the ERG25 gene was resistant to PF1163A. ERG25p is a C-4 sterol methyl oxidase known to be essential for the viability of yeast and fungi because of the known role of ERG25 gene disruption in S. cerevisiae-led lethality. ERG25p is the Enzyme responsible for the first step in the removal of the two methyl groups at the C-4 position of sterol. From the results obtained here, we conclude that PF1163A is a novel natural Antifungal that inhibits C-4 sterol methyl oxidase.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-123457
    Antifungal Agent/C-4 Sterol Methyl Oxidase Inhibitor